Skip to main content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.

Covid-19 HSE Clinical Guidance and Evidence

* Phone users, please scroll down to view content. Queries to: clinicaldesign@hse.ie

Cancer Care Navigation

Cancer Care - Radiation Oncology

Interim Clinical Guidance

| NCCP guidance on the use of PPE by medical professionals when managing patients requiring radiotherapy in response to the current novel coronavirus (COVID-19) pandemic (CD 19-063 002/27.04.20)
| NCCP advice for Medical Professionals on the management of patients undergoing Breast Cancer Radiotherapy in response to COVID-19 (CD 19-064 001/17.04.20)
| NCCP advice on radiation therapy capacity escalation plan in response to the current COVID 19 pandemic (CD 19-096 002/17.08.20)
| NCCP advice for medical professionals on the management of patients undergoing Prostate Cancer Radiotherapy in response to the current novel coronavirus (COVID-19) pandemic (CD 19-097-001/02.07.20)
| NCCP advice on the management of patients undergoing radiation oncology treatment, in response to the current novel coronavirus (COVID-19) pandemic (CD 19-100-004/28.09.20)
| NCCP advice for medical professionals on the management of Thyroid Cancer and Overactive Thyroid Disease in response to COVID-19 (CD 19-092 001/08.05.20)
| NCCP advice for medical professionals on the treatment of patients with CNS tumours with radiotherapy in response to the COVID-19 pandemic (CD 19-183/16.06.20)
| NCCP guidance for Medical Professionals on the management of patients with head and neck cancer undergoing radiotherapy in response to the current COVID-19 pandemic (CD 19-182/16.06.20)
| NCCP advice for medical professionals on the management of patients undergoing lung cancer radiotherapy in response to the current novel coronavirus COVID 19 pandemic (CD 19-186/18.06.20)
| NCCP patient pathway for attendance for radiation oncology during the COVID-19 pandemic (CD 19-178 002/02.07.20) (Download PDF)
| NCCP advice for medical professionals on acceptable dose fractionation during the novel coronavirus COVID-19 pandemic (NCD19-022-001/24.08.20)
| Guidance on the Management of Treatment Gaps and Interruptions in Radical Fractionated Radiotherapy Arising from the COVID 19 Pandemic (NCD19-026/25.08.20) (Download PDF)

National Health Library & Knowledge Service. Health Service Executive. Dr. Steevens' Hospital, Dublin 8. Tel: 01-6352555/8. Email: hselibrary@hse.ie

Disclaimer